Niva Bupa Health Insurance Company Ltd (NIVABUPA)
₹72.65
Mkt cap
₹13,435 Cr
P/E ratio
77.10
P/B
3.54
Div yield
0.00%
ROE
3.46%
ROCE
3.15%
EPS (TTM)
₹0.94
Book value
₹21
52W range
68–91
Sector
Financial Services
Price history
Previous close
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India. [1]
NSE NIVABUPABSE 544286
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsBearish
52-week range
−20.51% from high₹73
₹68+7.63% from low₹91
Current
₹72.65
Prev close
₹72.82
Day
−0.23%
Price performance
1D
−0.16%
1W
+1.07%
1M
−0.79%
3M
−15.39%
6M
−7.68%
1Y
−2.55%
YTD
−3.34%
Financials
Revenue, profit & margin
P/E ratio
77.1×
NIVABUPA is 149% above the sector median of 30.9×
NIVABUPA77.1×
Sector median30.9×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 969 | 1,026 | 1,316 | 1,124 | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 | 1,611 | 2,251 | 2,471 | |
| Expenses | 1,027 | 1,071 | 1,215 | 1,228 | 1,387 | 1,282 | 1,420 | 1,834 | 1,627 | 1,705 | 2,069 | 2,287 | |
| Operating Profit | -58 | -46 | 100 | -103 | -66 | -24 | 251 | 98 | -53 | -94 | 182 | 184 | |
| OPM % | -6% | -4.4% | 8% | -9% | -5.0% | -1.9% | 15% | 5% | -3.4% | -6% | 8% | 7% | |
| Other Income | 50 | 50 | 57 | 84 | 79 | 37 | -45 | -0 | 18 | 7 | -1 | -0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 98 | -35 | -88 | 181 | 184 | |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 27% | 0% | 0% | 12% | 25% | |
| Net Profit | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 71 | -35 | -88 | 159 | 138 | |
| EPS in Rs | 0.07 | 1.13 | 0.39 | -0.19 | -0.47 | 0.86 | 0.75 | ||||||
| Raw PDF |
Earnings
Results dates & reactionsNext results
4 Nov '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.07% · closed higher next day 3 of last 5
| Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | |
|---|---|---|---|---|---|
| Broadcast | 8 May '25◦ | 31 Jul '25◦ | 3 Nov '25◦ | 29 Jan '26◦ | 8 May '26◦ |
| Earnings day | −0.65% | −6.90% | +3.16% | +1.01% | +3.72% |
| +1 day | −2.55% | −6.34% | +1.85% | +1.82% | +3.04% |
| +5 days | +3.56% | −8.64% | +3.23% | −0.51% | −1.60% |
| +15 days | +5.72% | −4.23% | +2.23% | −1.49% | +3.37% |
| +30 days | −7.04% | −6.52% | +1.03% | −8.24% | +6.63% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202655.29%Promoter
Promoters55.29%
FIIs12.95%0.86
DIIs15.89%0.28
Public15.88%0.56
Ownership trend
Peers
6 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| ICICI Lombard | ₹1,580.80 | 30.92 | 78,998 | 0.85% | 946 | +15.48% | 8,220 | +19.66% | 21.88% |
| General Insuranc | ₹310.85 | 6.08 | 54,536 | 4.26% | 2,966 | +3.21% | 14,985 | +17.48% | 17.35% |
| Star Health Insu | ₹530.40 | 29.62 | 31,221 | 0.00% | 265 | +232.76% | 5,341 | +17.11% | 9.69% |
| New India Assura | ₹158.94 | — | 26,193 | 0.94% | −1,249 | −2,413.63% | 13,721 | +2.02% | 4.29% |
| Go Digit General | ₹260.60 | 48.96 | 24,109 | 0.00% | 86 | −37.55% | 2,427 | +8.54% | 13.10% |
| Niva Bupa Health | ₹72.65 | 77.10 | 13,435 | 0.00% | 138 | +92.89% | 2,471 | +27.93% | 3.15% |
| Median: 6 Co. | ₹285.73 | 30.92 | 28,707 | 0.42% | 201 | +9.35% | 6,781 | +17.30% | 11.39% |
Filings
Annual reports2
Concall transcripts19
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Oct - Niva Bupa will hold Q2FY27 earnings conference call on November 4, 2026 at 5:30 PM IST.Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter And Half-Year Ended September 30, 2026. 24 Oct - Board meets on November 4, 2026 to approve Q2 and half-year unaudited results; trading window closed till November 6.Announcement under Regulation 30 (LODR)-Demise 19 Oct - Mr. Roger William John Davis, Non-Executive Director, died on October 17, 2026; he ceased board role.Announcement under Regulation 30 (LODR)-Credit Rating 15 Oct - India Ratings assigned IND AAA/Stable to proposed 500 crore subordinated debt.Intimation Of Call Option Notice 15 Oct - Niva Bupa exercises call option on ₹150 crore debentures; redemption on November 13, 2026.